Gour Medical SA and SolMic Research GmbH signed an exclusive cooperation agreement to manufacture and commercialize Cannabidiol (CBD) products for a use in animal healthcare.

SBA Member News, 22.09.2015

Gour will exclusively commercialize Cannabidiol (CBD) products from SolMic for animal healthcare and market them worldwide.

About Gour Medical SA
Gour Medical SA, founded in 2014, is a Swiss based veterinary biomedical company, leveraging the advances in human research and applying them to medical solutions for companion animals. Integrated and innovative therapeutic solutions developed by Gour address companion animals' unmet medical needs by treating or preventing significant companion animal health issues. Gour has already signed several cooperation agreements with world renowned companies and laboratories for the development and commercialization of various animal healthcare products.

About SolMic Research GmbH
SolMic is focused on the development, production and distribution of innovative products that are based on a proprietary solubilisation technology platform in the area of micelle engineering. It allows a high level of bioavailability of orally or topically administered ingredients and creation of unique blends of active principles. SolMic has developed unique nutraceutical products targeting wellness and various disease conditions marketed through partnerships in EU and US.

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…